Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Century Therapeutics, Inc. Common Stock

Century Therapeutics focuses on developing allogeneic, iPSC-derived NK and T cell therapies for the treatment of cancer and autoimmune diseases.

COM:CENTURYTX

Century Therapeutics

Last Close

1.24

22/11 21:00

Market Cap

102.89M

Beta: -

Volume Today

511.90K

Avg: -